OX40-enhanced tumor rejection and effector T cell differentiation decreases with age

由 Ruby, Carl E., Weinberg, Andrew D.
發表在 J Immunol (2009)

The role of OX40-mediated co-stimulation in T cell activation and survival

由 Redmond, William L., Ruby, Carl E., Weinberg, Andrew D.
出版 2009

The impact of age on a mitoxantrone-based tumor vaccine

由 Stonewall, Keven, Quintero, Cecilia, Zloza, Andrew, Kaufman, Howard, Ruby, Carl
出版 2013

Current status of granulocyte–macrophage colony-stimulating factor in the immunotherapy of melanoma

由 Kaufman, Howard L, Ruby, Carl E, Hughes, Tasha, Slingluff, Craig L
出版 2014

OX40 engagement stabilizes Mxd4 and Mnt protein levels in antigen-stimulated T cells leading to an increase in survival

由 Vasilevsky, Nicole A., Ruby, Carl E., Hurlin, Peter J., Weinberg, Andrew D.
出版 2011

Optimal Management of Metastatic Melanoma: Current Strategies and Future Directions

由 Batus, Marta, Waheed, Salman, Ruby, Carl, Petersen, Lindsay, Bines, Steven D., Kaufman, Howard L.
出版 2013

Mutations in PIK3CA sensitize breast cancer cells to physiologic levels of aspirin

由 Turturro, Sanja B., Najor, Matthew S., Ruby, Carl E., Cobleigh, Melody A., Abukhdeir, Abde M.
發表在 Breast Cancer Res Treat (2016)

Fasting reduces the incidence of vincristine‐associated adverse events in dogs

由 Duckett, Margaret E., Curran, Kaitlin M., Leeper, Haley J., Ruby, Carl E., Bracha, Shay
發表在 Vet Comp Oncol (2020)

Caloric restriction maintains OX40 agonist-mediated tumor immunity and CD4 T cell priming during aging

由 Farazi, Michelle, Nguyen, Justine, Goldufsky, Josef, Linnane, Stephanie, Lukaesko, Lisa, Weinberg, Andrew D., Ruby, Carl E.
出版 2014

Interleukin-2 alters distribution of CD144 (VE-cadherin) in endothelial cells

由 Kim, Dae Won, Zloza, Andrew, Broucek, Joseph, Schenkel, Jason M, Ruby, Carl, Samaha, Georges, Kaufman, Howard L
出版 2014

Combination immunotherapy with Interleukin-2 and CTLA-4 blockade decreases tumor growth and improves overall survival

由 Broucek, Joseph R, Hughes, Tasha, Huelsmann, Erica J, Poshepny, Joseph L, Ruby, Carl E, Zloza, Andrew, Kaufman, Howard L
出版 2013

Pseudomonas aeruginosa exotoxin T induces potent cytotoxicity against a variety of murine and human cancer cell lines

由 Goldufsky, Joe, Wood, Stephen, Hajihossainlou, Behnam, Rehman, Tooba, Majdobeh, Omar, Kaufman, Howard L., Ruby, Carl E., Shafikhani, Sasha H.
發表在 J Med Microbiol (2015)

Combination immunotherapy with anti-CTLA-4 and interleukin-2 redirects regulatory T cells into tumor-draining lymph nodes and expands anti-tumor CD8+ T cells in the tumor microenvi...

由 Broucek, Joseph, Hughes, Tasha, Huelsmann, Erica, Lusciks, Eugene, Hill , Graham, Zayas, Janet, Poshepny, Joseph, Ruby , Carl, Kohlhapp, Frederick, Zloza, Andrew, Kaufman, Howard
發表在 J Immunother Cancer (2014)

OX40 Agonists can drive Treg expansion if the cytokine milieu is right

由 Ruby, Carl E, Yates, Melissa A, Hirschhorn-Cymerman, Daniel, Chlebeck, Peter, Wolchok, Jedd D, Houghton, Alan N, Offner, Halina, Weinberg, Andrew D
發表在 J Immunol (2009)

Oncolytic virus therapy for cancer

由 Goldufsky, Joe, Sivendran, Shanthi, Harcharik, Sara, Pan, Michael, Bernardo, Sebastian, Stern, Richard H, Friedlander, Philip, Ruby, Carl E, Saenger, Yvonne, Kaufman, Howard L
發表在 Oncolytic Virother (2013)

Exosomal proteomic signatures correlate with drug resistance and carboplatin treatment outcome in a spontaneous model of canine osteosarcoma

由 Weinman, Marcus A., Ramsey, Stephen A., Leeper, Haley J., Brady, Jacqueline V., Schlueter, Andrew, Stanisheuski, Stanislau, Maier, Claudia S., Miller, Tasha, Ruby, Carl E., Bracha, Shay
發表在 Cancer Cell Int (2021)

Inhibition of p70 S6 Kinase (S6K1) Activity by A77 1726 and Its Effect on Cell Proliferation and Cell Cycle Progress()()

由 Doscas, Michelle E., Williamson, Ashley J., Usha, Lydia, Bogachkov, Yedida, Rao, Geetha S., Xiao, Fei, Wang, Yimin, Ruby, Carl, Kaufman, Howard, Zhou, Jingsong, Williams, James W., Li, Yi, Xu, Xiulong
出版 2014

A Preliminary Proteomic Investigation of Circulating Exosomes and Discovery of Biomarkers Associated with the Progression of Osteosarcoma in a Clinical Model of Spontaneous Disease...

由 Brady, Jacqueline V., Troyer, Ryan M., Ramsey, Stephen A., Leeper, Haley, Yang, Liping, Maier, Claudia S., Goodall, Cheri P., Ruby, Carl E., Albarqi, Hassan A.M., Taratula, Oleh, Bracha, Shay
發表在 Transl Oncol (2018)

NK cells and CD8+ T cells cooperate to improve therapeutic responses in melanoma treated with interleukin-2 (IL-2) and CTLA-4 blockade

由 Kohlhapp, Frederick J, Broucek, Joseph R, Hughes, Tasha, Huelsmann, Erica J, Lusciks, Jevgenijs, Zayas, Janet P, Dolubizno, Hubert, Fleetwood, Vidyaratna A, Grin, Alisa, Hill, Graham E, Poshepny, Joseph L, Nabatiyan, Arman, Ruby, Carl E, Snook, Joshua D, Rudra, Jai S, Schenkel, Jason M, Masopust, David, Zloza, Andrew, Kaufman, Howard L
發表在 J Immunother Cancer (2015)

Signaling through OX40 Enhances Anti-tumor Immunity

由 Jensen, Shawn M., Maston, Levi D., Gough, Michael J., Ruby, Carl E., Redmond, William L., Crittenden, Marka, Li, Yuhuan, Puri, Sachin, Poehlein, Christian H., Morris, Nick, Kovacsovics-Bankowski, Magdalena, Moudgil, Tarsem, Twitty, Chris, Walker, Edwin B., Hu, Hong-Ming, Urba, Walter J., Weinberg, Andrew D., Curti, Brendan D, Fox, Bernard A.
出版 2010